IDH1 GENE MUTATION
Clinical trials for IDH1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new IDH1 GENE MUTATION trials appear
Sign up with your email to follow new studies for IDH1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bone cancer: targeted drug AG-120 tested in small trial
Disease control OngoingThis study tests whether the drug AG-120 can safely slow or stop the growth of a rare bone cancer called chondrosarcoma that has a specific IDH1 gene mutation. Six adults with advanced or recurrent grade 2 or 3 chondrosarcoma will receive the drug. The main goal is to see how lon…
Matched conditions: IDH1 GENE MUTATION
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for young brain tumor patients: drug combo targets IDH mutations
Disease control OngoingThis early-phase study tests a new drug (BGB-290) combined with chemotherapy (temozolomide) in teens and young adults with a type of brain tumor called glioma that has an IDH mutation. The goal is to find the safest dose and see how well the combination works for both newly diagn…
Matched conditions: IDH1 GENE MUTATION
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC